Coenzyme Q10 in atherosclerosis

Eur J Pharmacol. 2024 May 5:970:176481. doi: 10.1016/j.ejphar.2024.176481. Epub 2024 Mar 15.

Abstract

Atherosclerotic disease is a chronic disease that predominantly affects the elderly and is the most common cause of cardiovascular death worldwide. Atherosclerosis is closely related to processes such as abnormal lipid transport and metabolism, impaired endothelial function, inflammation, and oxidative stress. Coenzyme Q10 (CoQ10) is a key component of complex Ⅰ in the electron transport chain and an important endogenous antioxidant that may play a role in decelerating the progression of atherosclerosis. Here, the different forms of CoQ10 presence in the electron transport chain are reviewed, as well as its physiological role in regulating processes such as oxidative stress, inflammatory response, lipid metabolism and cellular autophagy. It was also found that CoQ10 plays beneficial effects in atherosclerosis by mitigating lipid transportation, endothelial inflammation, metabolic abnormalities, and thrombotic processes from the perspectives of molecular mechanisms, animal experiments, and clinical evidence. Besides, the combined use of CoQ10 with other drugs has better synergistic therapeutic effects. It seems reasonable to suggest that CoQ10 could be used in the treatment of atherosclerotic cardiovascular diseases while more basic and clinical studies are needed.

Keywords: Atherosclerosis; Coenzyme Q10; Inflammation; Lipid metabolism; Oxidative stress.

Publication types

  • Review

MeSH terms

  • Aged
  • Animals
  • Atherosclerosis* / drug therapy
  • Humans
  • Inflammation / drug therapy
  • Lipids
  • Ubiquinone* / analogs & derivatives*
  • Ubiquinone* / pharmacology
  • Ubiquinone* / therapeutic use

Substances

  • coenzyme Q10
  • Ubiquinone
  • Lipids